Journalists working on stories related to high-risk pregnancies or the Society for Maternal-Fetal Medicine can contact Greg Phillips, Director of Communications, at press@smfm.org for referrals to MFM experts and to request additional information. The press office is open Monday through Friday from 9:00 AM to 5:00 PM ET.
Authors: The Society for Maternal-Fetal Medicine (SMFM) Coding Committee; Steve Rad, MD, FACOG; Brad Hart, MBA, MS, CPC, CPMA, COBGC; Vanita Jain, MD, FACOG. Background: First trimester screening includes biochemical markers, fetal nuchal translucency (NT) assessment via ultrasound (CPT 76813;... Continue Reading
The Society for Maternal-Fetal Medicine (SMFM) Coding Committee: Vanita Jain, MD; Amie Hollard, MD; Steve Rad MD; Trish Malisch, CCS-P, CPC; Fadi Bsat, MD. Testing for chromosome abnormalities should be an informed patient choice, based on information from a medical provider accounting for the... Continue Reading
Cell-free fetal DNA (cfDNA) screening has enhanced the ability to offer early aneuploidy screeningin pregnancy. The purpose of this White Paper is to describe billing recommendations when cfDNAscreening is done or considered in conjunction with first trimester Nuchal Translucency screening(CPT... Continue Reading
